Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 155 | nsp1:E155D; | CL-3e; |
| 159 | nsp1:E159K; | CL-3d; |
| 172 | nsp1:E172-; | CL-3b; |
| 172 | nsp1:E172G; | CL-3c; |
| 172 | nsp1:E172K; | CL-3d; |
| 176 | nsp1:E176D; | CL-1a;CL-3e; |
| 176 | nsp1:E176G; | CL-3b;CL-3f; |
| 36 | nsp1:E36D; | CL-3b;CL-3d;CL-3e; |
| 36 | nsp1:E36K; | CL-3e; |
| 37 | nsp1:E37G; | CL-3d; |
| 41 | nsp1:E41-; | CL-1a_3f;CL-3d;CL-3e; |
| 41 | nsp1:E41G; | CL-3f; |
| 41 | nsp1:E41K; | CL-2;CL-3c_3f;CL-3d; |
| 55 | nsp1:E55-; | CL-3e;CL-3f; |
| 55 | nsp1:E55G; | CL-2;CL-3e; |
| 57 | nsp1:E57-; | CL-3b;CL-3f; |
| 57 | nsp1:E57D; | CL-1a;CL-2; |
| 57 | nsp1:E57G; | CL-1a_3e;CL-3e; |
| 65 | nsp1:E65-; | CL-3c;CL-3e;CL-3f; |
| 65 | nsp1:E65A; | CL-3e; |
| 87 | nsp1:E87-; | CL-1a_3b;CL-2;CL-3b;CL-3e;CL-3f; |
| 87 | nsp1:E87K; | CL-2;CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
| 91 | nsp1:E91-; | CL-3b;CL-3e; |
| 93 | nsp1:E93-; | CL-1a_3c;CL-3b;CL-3e;CL-3f; |
| 93 | nsp1:E93A; | CL-3e; |
| 143 | nsp1:F143C; | CL-3d; |
| 143 | nsp1:F143I; | CL-3c; |
| 143 | nsp1:F143S; | CL-1b; |
| 157 | nsp1:F157-; | CL-2;CL-5; |
| 157 | nsp1:F157L; | CL-3e; |
| 31 | nsp1:F31-; | CL-3c;CL-3e;CL-5; |
| 31 | nsp1:F31L; | CL-3b; |
| 31 | nsp1:F31R; | CL-1a_3e; |
| 70 | nsp1:F70-; | CL-3b;CL-3c;CL-3e; |
| 8 | nsp1:F8L; | CL-3d; |
| 101 | nsp1:G101-; | CL-3e;CL-3f; |
| 105 | nsp1:G105-; | CL-3c; |
| 105 | nsp1:G105S; | CL-2;CL-3d; |
| 105 | nsp1:G105V; | CL-3b; |
| 112 | nsp1:G112-; | CL-3b;CL-3e;CL-3f; |
| 112 | nsp1:G112C; | CL-3b;CL-3e; |
| 112 | nsp1:G112D; | CL-1b; |
| 112 | nsp1:G112V; | CL-3e; |
| 127 | nsp1:G127D; | CL-3b; |
| 127 | nsp1:G127V; | CL-3c; |
| 130 | nsp1:G130E; | CL-5; |
| 130 | nsp1:G130R; | CL-3f; |
| 132 | nsp1:G132-; | CL-1b;CL-3b;CL-3d;CL-3e; |
| 132 | nsp1:G132S; | CL-3b;CL-3d; |
| 133 | nsp1:G133C; | CL-1a_3e;CL-3b;CL-3d;CL-3e;CL-5; |
Page 222 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com